Several new treatment combinations have been approved in metastatic renal cell carcinoma (mRCC). To determine the optimal therapy on the basis of cost and health outcomes, we performed a ...

We need a metric to understand the value of cancer treatments—this issue is not under debate. In recent months, different professional societies have produced tools to attempt to assess value, but ...

Data on the cost-effectiveness of the behavioral treatment of obesity are not conclusive. The cost-effectiveness of treatment in primary care settings is particularly relevant. We conducted a ...